Filing Details
- Accession Number:
- 0000899243-22-016532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-04 07:00:20
- Reporting Period:
- 2022-05-02
- Accepted Time:
- 2022-05-04 07:00:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1827087 | Vigil Neuroscience Inc. | VIGL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1279281 | Ivana Magovcevic-Liebisch | Vigil Neuroscience, Inc. 1 Broadway, 7Th Floor, Suite 07-300 Cambridge MA 02142 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-05-02 | 4,000 | $3.61 | 202,687 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-05-03 | 1,000 | $3.94 | 203,687 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.27 to $3.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.89 to $4.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price at which the transactions were effected.
Billionaire Hedge Funds
